Text Size

Development of an Urticaria Control Test (UCT-D)

This study is currently recruiting participants.
Verified February 2013 by Charite University, Berlin, Germany
Sponsor:
Information provided by (Responsible Party):
K. Weller, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01610128
First received: May 30, 2012
Last updated: February 14, 2013
Last verified: February 2013
History of Changes
  Purpose

The aim of the project is to develop a patient reported outcome instrument to assess disease control in chronic urticaria patients (Urticaria Control Test - UCT) of age 12 and older.


Condition
Chronic Urticaria

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: UCT - Development of an Instrument to Assess Disease Control in Patients With Chronic Urticaria (Urticaria Control Test)

Resource links provided by NLM:

MedlinePlus related topics: Hives
U.S. FDA Resources

Further study details as provided by Charite University, Berlin, Germany:

Estimated Enrollment: 300
Study Start Date: October 2011
Estimated Study Completion Date: August 2013
Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
chronic urticaria patients
all patients suffering from chronic types of urticaria (chronic spontaneous urticaria as well as chronic inducible forms such as cold contact urticaria)

  Eligibility

Ages Eligible for Study:   12 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

all patients suffering from chronic forms of urticaria

Criteria

Inclusion Criteria:

all patients suffering from chronic forms of urticaria are eligible

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01610128

Contacts
Contact: Karsten Weller, MD karsten.weller@charite.de

Locations
Germany
Universitätshautklinik Mainz Recruiting
Mainz, Rheinland-Pfalz, Germany, 55131
Contact: Petra Staubach, MD         petra.staubach@unimedizin-main.de    
Principal Investigator: Petra Staubach, MD            
Allergie-Centrum-Charite Recruiting
Berlin, Germany, 10117
Contact: Karsten Weller, MD         karsten.weller@charite.de    
Contact: Marcus Maurer, MD         marcus.maurer@charite.de    
Principal Investigator: Karsten Weller, MD            
Sponsors and Collaborators
Charite University, Berlin, Germany
  More Information

No publications provided

Responsible Party: K. Weller, Principal Investigator, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier: NCT01610128     History of Changes
Other Study ID Numbers: UCT-D
Study First Received: May 30, 2012
Last Updated: February 14, 2013
Health Authority: Germany: Ethics Commission

Keywords provided by Charite University, Berlin, Germany:
urticaria, patient reported outcome

Additional relevant MeSH terms:
Urticaria
Skin Diseases, Vascular
Skin Diseases
 Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on May 23, 2013